HIF inhibitor JNJ-42041935, Purity ≥98%

Cat. No.: X24-06-ZQ475

HIF inhibitor JNJ-42041935, Purity ≥98%

Synonym: 1193383-09-3; HIF inhibitor; JNJ 42041935

  • MDL: MFCD25541711
  • CAS Number: 1193383-09-3
  • Compound CID: 45102710
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
JNJ-42041935 is designed to disrupt the hypoxia-inducible factor (HIF) pathway, aiming to hinder cancer cell survival and adaptation in low-oxygen environments characteristic of tumor growth.
Molecular Weight
346.65
Molecular Formula
C12H6ClF3N4O3
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
JNJ-42041935 is employed as a HIF inhibitor to explore treatments for ischemic and neoplastic diseases.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0